CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,206 Cr | ₹2,686 Cr | ₹2,177 Cr | ₹1,730 Cr | ₹1,364 Cr |
What is the latest Total Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,206 Cr |
| Mar2024 | ₹2,686 Cr |
| Mar2023 | ₹2,177 Cr |
| Mar2022 | ₹1,730 Cr |
| Mar2021 | ₹1,364 Cr |
How is Total Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,206 Cr | 19.36 | |
| Mar2024 | ₹2,686 Cr | 23.34 | |
| Mar2023 | ₹2,177 Cr | 25.85 | |
| Mar2022 | ₹1,730 Cr | 26.88 | |
| Mar2021 | ₹1,364 Cr | - | |
Compare Total Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹18,902.3 Cr | -4.9% | -0.2% | 19.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -4.9% |
-0.2% |
19.3% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses